New method for determining prognosis of patients with psoriasis (E-PAP)

Journal of Dermatological Science

Volumn 16, Issue 2, 1998, Pages 165-169

  Sugai, Junichi ^a   Ozawa, Akira ^a   Kawakubo, Yo ^a   Iizuka, Mariko ^a   Miyahara, Motomi ^a   Ohkido, Muneo ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclosporin; E PAP; Long term intermittent therapy; Long term uninterrupted monotherapy; PASI; Psoriasis

Indexed keywords

CYCLOSPORIN A;

ARTICLE; CALCULATION; CLINICAL ARTICLE; DRUG EFFECT; HUMAN; HYPERTENSION; HYPERURICEMIA; NEPHROTOXICITY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; REMISSION; SYMPTOM; TECHNIQUE;

EID: 0030635278     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(97)00047-9     Document Type: Article

References (5)

1. [1] Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica (GASEL) 1978;157:238-44.
2. [2] Marks A, Barton PS, Shuttleworth D, Finlay YA. Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:235-40.
3. [3] Feldman SR, Fleischer AB Jr., Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996;106:183-6.
4. [4] Nakayama J, Hori Y, Nakagawa H, Ishibashi Y, Horikoshi T, Ozawa A, Sugai J, Ohkido M. Eur J Dermatol 1996;6:341-3.
5. [5] Fleischer AB Jr., Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR, Rajashekhar V. Disease severity measures in a population of psoriasis patients: the self-administered psoriasis area severity index scores. J Invest Dermatol 1996;107:26-9.